The company#39;s wholly owned subsidiary Orit Laboratories LLC has received approval from the US Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Glycopyrrolate tablets USP in the strengths of 1 mg and 2mg, Alembic Pharmaceuticals said in a BSE filing.from Moneycontrol Business News https://ift.tt/2Qgj9ks
No comments:
Post a Comment